Stock Research for SRNE

SRNE
Current Price

$8.7750


Latest Update: 2018-02-16 16:00:00

High
$ 8.8000
Low
$ 8.7500
Close
$ 8.7500
Volume
50606
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

SRNE Stock Chart & Research Data

The SRNE chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SRNE chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


SRNE Due diligence Resources & Stock Charts

The SRNE stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View SRNE Detailed Price Forecast - CNN Money CNN View SRNE Detailed Summary - Google Finance
Yahoo View SRNE Detailed Summary - Yahoo! Finance Zacks View SRNE Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View SRNE Trends & Analysis - Trade-Ideas Barrons View SRNE Major Holders - Barrons
NASDAQ View SRNE Call Transcripts - NASDAQ Seeking View SRNE Breaking News & Analysis - Seeking Alpha
Spotlight View SRNE Annual Report - CompanySpotlight.com OTC Report View SRNE OTC Short Report - OTCShortReport.com
TradeKing View SRNE Fundamentals - TradeKing Charts View SRNE SEC Filings - Bar Chart
WSJ View Historical Prices for SRNE - The WSJ Morningstar View Performance/Total Return for SRNE - Morningstar
MarketWatch View the Analyst Estimates for SRNE - MarketWatch CNBC View the Earnings History for SRNE - CNBC
StockMarketWatch View the SRNE Earnings - StockMarketWatch MacroAxis View SRNE Buy or Sell Recommendations - MacroAxis
Bullish View the SRNE Bullish Patterns - American Bulls Short Pains View SRNE Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View SRNE Stock Mentions - StockTwits PennyStocks View SRNE Stock Mentions - PennyStockTweets
Twitter View SRNE Stock Mentions - Twitter Invest Hub View SRNE Investment Forum News - Investor Hub
Yahoo View SRNE Stock Mentions - Yahoo! Message Board Seeking Alpha View SRNE Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for SRNE - SECform4.com Insider Cow View Insider Transactions for SRNE - Insider Cow
CNBC View SRNE Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for SRNE - OTC Markets
Yahoo View Insider Transactions for SRNE - Yahoo! Finance NASDAQ View Institutional Holdings for SRNE - NASDAQ


Stock Charts

FinViz View SRNE Stock Insight & Charts - FinViz.com StockCharts View SRNE Investment Charts - StockCharts.com
BarChart View SRNE Stock Overview & Charts - BarChart Trading View View SRNE User Generated Charts - Trading View


Latest Financial News for SRNE

3 Biotech Stocks That Soared This Week: Are They Buys?
Posted on Saturday February 17, 2018

These biotechs have promising pipeline candidates -- but can their sizzling stock momentum continue?


Why Sorrento Therapeutics Jumped Higher Today
Posted on Thursday February 15, 2018

Investors crowd into the biotech ahead of a potential approval at the end of the month.


Celularity Announces $250M in Funding to Deliver Treatments for Cancer, Inflammatory and Degenerative Diseases, and Functional Regeneration
Posted on Thursday February 15, 2018

WARREN, N.J. , Feb. 15, 2018 /PRNewswire/ --  Celularity has been created through the contribution and acquisition of extensive intellectual property, clinical-stage assets, basic and clinical research, ...


Does Sorrento Therapeutics Inc’s (NASDAQ:SRNE) Past Performance Indicate A Stronger Future?
Posted on Wednesday February 14, 2018

When Sorrento Therapeutics Inc’s (NASDAQ:SRNE) announced its latest earnings (30 September 2017), I wanted to understand how these figures stacked up against its past performance. The two benchmarks I usedRead More...


Why Sorrento Therapeutics Jumped Higher Today
Motley Fool - Feb 15, 2018
Sorrento is expecting the Food and Drug Administration to rule on its marketing application for ZTlido, a lidocaine patch to treat post-herpetic neuralgia -- the pain caused by shingles -- on or about Feb. 28.
Drilling Down Into Sorrento Therapeutics, Inc. (SRNE) - StockNewsJournal
Sorrento Therapeutics Inc (NASDAQ:SRNE) Major Shareholder Sells $5173217.28 in ... - The Ledger Gazette

Why Sorrento Therapeutics Inc Jumped Higher Today
Motley Fool - Jan 22, 2018
Like Juno Therapeutics, Sorrento is also developing cancer treatments called chimeric antigen receptor T-cell (CAR-T) therapies that train a patient's immune cells to attack tumor cells.
Could Sorrento Therapeutics be the next minnow gobbled up in biotech feeding ... - Proactive Investors UK

Sorrento Therapeutics, Inc. Chairman/CEO letter to stockholders
GlobeNewswire (press release) - Feb 5, 2018
Since its inception in 2006, Sorrento Therapeutics, Inc. (“Sorrento”) has continued to evolve as a dynamic, forward-focused biopharmaceutical company with unwavering goals of becoming a recognized and respected leader and major player in antibody-based ...

Sorrento Therapeutics CEO Dr Ji to Present at LEERINK Partners 7th Global ...
GlobeNewswire (press release) - Feb 2, 2018
This press release and any statements made for and during any presentation or meeting contain forward-looking statements related to Sorrento Therapeutics, Inc., under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform ...
Sorrento Therapeutics Inc. (SRNE) Soars 5.52% on February 02 - Equities.com

Enter a stock symbol to view the stock details.